In non-small cell lung cancer (NSCLC), MALAT1 is overexpressed and enhances tumor cell proliferation, migration, and invasion by activating signaling pathways such as ERK/MAPK and Akt/mTOR, thereby promoting bone metastasis [104,105,106]. Here, MTOR is linked to non-small cell lung carcinoma.